Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Use financial data to refine your budget with practical steps that help identify waste and improve allocation. This intro explains a data-driven approach to smarter budgeting.
27,071 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Oil traders confront a rare overbought signal as crude-oil futures haven’t been this overstretched in decades. Market...
In a market obsessed with the next AI breakthrough, one stock stands out not for hype but for real, lasting traction....
OpenAI’s CFO unveils a four-question framework to assess whether AI spending actually delivers value. The approach fo...
A major insider sale at LegalZoom prompts questions for investors. This guide breaks down what the move could mean, h...
A developing story says kevin warsh about make a major Fed change could roll back forward guidance at the mid-June FO...
A Paychex executive recently sold a small stake, raising questions about the stock's direction. This article explains...
U.S. stocks declined as oil surged on Middle East tensions, with the S&P 500 and tech shares under pressure. Markets ...
Nvidia is betting on a future where it sells complete AI production lines, not just chips. This shift could redefine ...
When insiders move shares, investors want to know why. This comprehensive guide breaks down why the electronic arts p...
A veteran strategist warns that the odds stock market meltdown could jump to 35% this year as oil shocks and sluggish...
A recent SEC Form 4 shows a Teladoc executive sold roughly $71,000 worth of stock. This article breaks down what that...